![](/img/cover-not-exists.png)
CANAGLIFLOZIN (CANA) REDUCES CARDIOVASCULAR (CV) AND RENAL EVENTS INDEPENDENT OF BASELINE HEART FAILURE (HF): A CREDENCE SECONDARY ANALYSIS
Sarraju, Ashish, Li, JingWei, Cannon, Christopher P., Chang, Tara I., Agarwal, Rajiv, Bakris, George L., Charytan, David M., de Zeeuw, Dick, Greene, Tom, Heerspink, Hiddo J.L., Levin, Adeera, Neal, BrVolume:
75
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(20)31645-4
Date:
March, 2020
File:
PDF, 253 KB
2020